Angelina PignaSenior Director, Commercial Accounting at Mirati Therapeutics, A Bristol-Myers Squibb CompanySpeaker
Profile
Angelina Pigna is a driven, strategic thinking leader with more than 30 years of pharma experience. She is currently the Sr. Director for Commercial Accounting at Mirati Therapeutics. Angelina has held various roles of increasing responsibility in finance, accounting, pricing and market access at large and small companies such as J&J, Schering Plough and Merck. Prior to joining Mirati, she consulted for 10 years within GTN and Market Access, leading the GTN Operational Consulting team. In addition, her experience has crossed over both brand and generic products with extensive focus on the oncologic and specialty areas. Angelina specializes in identifying process and methodological weaknesses to achieve optimal organization efficiencies.
Angelina provides thought leadership within Gross-to-Net (GTN) while driving results that establish best practices within the industry.
Agenda Sessions
Product Launch Readiness: Accounting policy, operational accounting, and financial reporting considerations for first time commercialization
, 2:00pmView Session